These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY. Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683 [Abstract] [Full Text] [Related]
4. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. El-Bawab H, Al-Sugair AA, Rafay M, Hajjar W, Mahdy M, Al-Kattan K. Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120 [Abstract] [Full Text] [Related]
5. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Gawande RS, Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE. Radiology; 2012 Feb; 262(2):613-22. PubMed ID: 22157202 [Abstract] [Full Text] [Related]
6. Reactive thymic hyperplasia following chemotherapy for children with lymphoma: computed tomography may be able to provide valuable information to avoid over-treatment. Tian L, Cai PQ, Cui CY, Mo YX, Gong X, Fan W. Eur J Cardiothorac Surg; 2015 May; 47(5):883-9. PubMed ID: 25079775 [Abstract] [Full Text] [Related]
7. Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders. Priola AM, Galetto G, Priola SM. Clin Imaging; 2014 May; 38(6):771-84. PubMed ID: 24997534 [Abstract] [Full Text] [Related]
8. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma. Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Moellers M, Buerke B, Stoevesandt D. Pediatr Blood Cancer; 2023 Aug; 70(8):e30421. PubMed ID: 37243889 [Abstract] [Full Text] [Related]
9. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Ustaalioglu BB, Seker M, Bilici A, Canpolat N, Yıldirim E, Kefeli U, Ustaalioglu R, Yilmaz BE, Salepci T, Ozdemir N, Gumus M. Med Oncol; 2011 Mar; 28(1):258-64. PubMed ID: 20155405 [Abstract] [Full Text] [Related]
10. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. AJR Am J Roentgenol; 1987 Aug; 149(2):269-72. PubMed ID: 3496749 [Abstract] [Full Text] [Related]
11. Characterization of thymic masses using (18)F-FDG PET-CT. Kumar A, Regmi SK, Dutta R, Kumar R, Gupta SD, Das P, Halanaik D, Jindal T. Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212 [Abstract] [Full Text] [Related]
12. Thymic hyperplasia following chemotherapy in adults with lymphoma: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation. Sun DP, Ding CY, Wang L, Liang JH, Fan L, Wu YJ, Tian T, Li TN, Xu W, Li JY. Leuk Lymphoma; 2015 Aug; 56(8):2344-9. PubMed ID: 25407653 [Abstract] [Full Text] [Related]
13. The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy. Kawano T, Suzuki A, Ishida A, Takahashi N, Lee J, Tayama Y, Oka T, Yokota S, Inoue T. Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):831-6. PubMed ID: 14963698 [Abstract] [Full Text] [Related]
14. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment. Jerushalmi J, Frenkel A, Bar-Shalom R, Khoury J, Israel O. J Nucl Med; 2009 Jun; 50(6):849-53. PubMed ID: 19443604 [Abstract] [Full Text] [Related]
15. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT. Tsuji K, Kishi S, Tsuchida T, Yamauchi T, Ikegaya S, Urasaki Y, Fujiwara Y, Ueda T, Okazawa H, Kimura H. J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444 [Abstract] [Full Text] [Related]
16. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Nakahara T, Fujii H, Ide M, Nishiumi N, Takahashi W, Yasuda S, Shohtsu A, Kubo A. Br J Radiol; 2001 Sep; 74(885):821-4. PubMed ID: 11560830 [Abstract] [Full Text] [Related]